Stocksigma LogoStocksigma Logo

Bio Medica Laboratories Claims Exemption from Q2 Corporate Governance Reporting

Bio Medica Laboratories Limited notified the NSE that the Corporate Governance Report under Regulation 27(2) of SEBI LODR Regulations, 2015 is not

Bio Medica Laboratories Claims Exemption from Q2 Corporate Governance Reporting

Bio Medica Laboratories Ltd · Others (Uncategorized) · 26 Oct 2026, 8:44 pm

Bio Medica Laboratories Claims Exemption from Q2 Corporate Governance Reporting Bio Medica Laboratories Limited notified the NSE that the Corporate Governance Report under Regulation 27(2) of SEBI LODR Regulations, 2015 is not applicable for Q2 ended 30th Sep'26. The company claimed exemption under Regulation 15(2) due to its listing on the NSE SME platform and maintaining paid-up equity capital below ₹10 cr and net worth below ₹25 cr. The company confirmed it will comply with the relevant governance provisions within six months should the regulations become applicable.

Original exchange filing (PDF)

More announcements from Bio Medica Laboratories Ltd

All Bio Medica Laboratories Ltd announcements